Healthc Inform Res Search


Code of Ethics

  • HOME
  • Code of Ethics

Research and Publication Ethics

The Journal adheres to the ethical guidelines for research and publication described in “Good Publication Practice Guidelines for Medical Journals 2nd. (” or “Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals (”

Conflict of Interest

Any potential conflicts of interest should be disclosed in the cover letter even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Examples of conflicts are financial support from or connections to commercial preferences, political pressure from interest groups, or academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated. The Editor will decide whether the information on the conflict should be included in the published paper.

Statement of Human and Animal Rights and Informed Consent

Any investigations involving humans and animals should be approved by the Institutional Review Board and Animal Care Committee, respectively, of the institution where the study took place. Healthcare Informatics Research (HIR) will not consider any studies involving humans or animals without the appropriate approval. Informed consent should be obtained, unless waived by the Institutional Review Board, from patients who participated in clinical investigations. Human subjects should not be identifiable, such that patients'names, hospital, identifiers, date of birth or other protected healthcare information should not be disclosed. The Journal adheres to the protected health information guideline described in “Guidance Regarding Methods for De-identification of Protected Health Information in Accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule (”. Distribution of gender and age of all subjects should be provided in the main text. If experiments involve animals, the research should be based on national or institutional guidelines for animal care and use. Species, strain, sex, and age of laboratory animals should be provided in the main text. Original articles submitted to HIR that address any investigation involving humans and animals should include a description about whether the study was conducted under an approval by the Institutional Review Board (with or without patient informed consent) and Animal Care Committee, respectively, of the institution where the study was conducted. HIR can request an approval by the Institutional Review Board or Animal Care Committee for other types of articles when necessary.


The HIR recommends that authorship be based on the following 4 criteria:
• Substantial contributors to the conception or design of the work; or the acquisition, analysis or interpretation of data for the work; AND
• Drafting the work or revising it critically for important intellectual content; AND
• Final approval of the version to be published; AND
• Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Only one first author and one corresponding author are recommended. In particular, the corresponding author is the only one individual who takes primary responsibility for communication with the journal during the manuscript submission, peer review, and publication process, and typically ensures that all the journal’s administrative requirement.

Originality, Duplicate, and Secondary Publication

All submitted manuscripts should be original and have not been published previously and are not being considered for publication by other journals. Any or all parts of the accepted manuscript should not be duplicated in any other journal without the permission of the Editorial Board. Original raw data must be available for review by the Editorial Board if required. Secondary publication may be justifiable only if the Instruction to Authors manuscript satisfies the six acceptable conditions of the ICMJE recommendations. If duplicate or secondary publication related to the papers of this journal is detected, the authors will be announced in the journal and their institutes will be informed, and there will also be penalties for the authors.

Plagiarism Detection

HIR uses the CrossCheck powered by iThenticate to detect instances of overlapping and similar text in submitted manuscripts. HIR checks all submitted manuscripts before peer review. CrossCheck is a plagiarism screening service that verifies the originality of content submitted before publication. CrossCheck checks submissions against millions of published research papers, and billions of web content.

Process to Manage Research and Publication Misconduct

When the Journal faces suspected cases of research and publication misconduct, such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, undisclosed conflict of interest, an ethical problem with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, etc., the resolution process will followed the flowchart provided by the Committee on Publication Ethics ( Discussions and decisions regarding suspected cases are carried out by the Committee of Publication Ethics of HIR.

Editorial Responsibilities

The editorial board will continuously work towards monitoring/safeguarding publication ethics in the following respects: providing guidelines for retracting articles; maintaining of the integrity of the academic record; precluding business needs from compromising intellectual and ethical standard; publishing corrections, clarifications, retractions, and apologies when needed; and avoiding plagiarism, and fraudulent data. Editors’ responsibilities shall include: responsibility and authority to reject/accept articles; avoiding conflicts of interest with respect to articles they reject/accept; accepting papers when reasonably certain; promoting the publication of corrections or retractions when errors are found; and preserving the anonymity of reviewers.

  • SCImago Journal & Country Rank


Browse all articles >

Editorial Office
1618 Kyungheegung Achim Bldg 3, 34, Sajik-ro 8-gil, Jongno-gu, Seoul 03174, Korea
Tel: +82-2-733-7637, +82-2-734-7637    E-mail:                

Copyright © 2020 by Korean Society of Medical Informatics. All rights reserved.

Developed in M2community

Close layer
prev next